Results

Brainstorm Cell Therapeutics Inc.

11/29/2021 | Press release | Distributed by Public on 11/29/2021 06:31

BrainStorm Cell Therapeutics Announces the Presentation of New Analyses from the Phase 3 Trial of NurOwn® in ALS at the 4th Annual ALS ONE Research Symposium